No significant differences were found for intensive care unit mortality ( 23 patients with BiPAP [ 5.5 % ] and 28 with high-flow nasal oxygen therapy [ 6.8 % ] ; P = .66 ) ( absolute difference , 1.2 % [ 95 % CI , -2.3 % to 4.8 % ] .